NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$44.26

Market cap

$1.09B

P/E Ratio

37.19

Dividend/share

$0.48

EPS

$1.19

Enterprise value

$1.08B

NRC Health is the leading provider of in-depth customer insights in healthcare.

Highlights
National Research's debt has decreased by 18% YoY and by 5% QoQ
National Research's equity has increased by 13% YoY and by 4.1% QoQ
NRC's net income is down by 19% YoY and by 3.5% QoQ
The EPS has declined by 17% year-on-year and by 2.5% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://nrchealth.com
Peers: NWBO

Key stats

What are the main financial stats of NRC
Market
Shares outstanding
24.57M
Market cap
$1.09B
Enterprise value
$1.08B
Valuations
Price to earnings (P/E)
37.19
Price to book (P/B)
14.01
Price to sales (P/S)
7.33
EV/EBIT
27.27
EV/EBITDA
23.91
EV/Sales
7.31
Earnings
Revenue
$148.47M
EBIT
$39.78M
EBITDA
$45.37M
Free cash flow
$21.26M
Per share
EPS
$1.19
Free cash flow per share
$0.86
Book value per share
$3.16
Revenue per share
$6.04
TBVPS
$2.87
Balance sheet
Total assets
$133.63M
Total liabilities
$55.88M
Debt
$19.96M
Equity
$77.75M
Working capital
$7.25M
Liquidity
Debt to equity
0.26
Current ratio
1.21
Quick ratio
1.02
Net debt/EBITDA
-0.06
Margins
EBITDA margin
30.6%
Gross margin
62.2%
Net margin
19.7%
Operating margin
28.1%
Efficiency
Return on assets
21.9%
Return on equity
39.9%
Return on invested capital
129.3%
Return on capital employed
39.8%
Return on sales
26.8%
Dividend
Dividend yield
1.08%
DPS
$0.48
Payout ratio
40.3%

NRC stock price

How has the National Research stock price performed over time
Intraday
-0.25%
1 week
-3.66%
1 month
5.28%
1 year
11.21%
YTD
18.66%
QTD
-0.25%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$148.47M
Gross profit
$92.37M
Operating income
$41.73M
Net income
$29.18M
Gross margin
62.2%
Net margin
19.7%
NRC's net income is down by 19% YoY and by 3.5% QoQ
National Research's net margin has decreased by 17% YoY and by 2.5% QoQ
NRC's operating income is down by 15% YoY and by 4.9% QoQ
National Research's operating margin has decreased by 13% YoY and by 4.1% QoQ

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
NRC P/E details
P/E
37.19
P/B
14.01
P/S
7.33
EV/EBIT
27.27
EV/EBITDA
23.91
EV/Sales
7.31
The EPS has declined by 17% year-on-year and by 2.5% since the previous quarter
The stock's price to earnings (P/E) is 15% more than its last 4 quarters average of 32.5 and 9% more than its 5-year quarterly average of 34.2
NRC's price to book (P/B) is 45% less than its 5-year quarterly average of 25.6
National Research's equity has increased by 13% YoY and by 4.1% QoQ
The P/S is 14% lower than the 5-year quarterly average of 8.5 but 10% higher than the last 4 quarters average of 6.7
National Research's revenue has decreased by 2.2% YoY

Efficiency

How efficient is National Research business performance
NRC's return on invested capital is down by 30% year-on-year and by 12% since the previous quarter
The return on sales has declined by 17% year-on-year and by 3.6% since the previous quarter
NRC's return on equity is down by 12% year-on-year and by 7% since the previous quarter
The return on assets has declined by 9% year-on-year and by 3.1% since the previous quarter

Dividends

What is NRC's dividend history
DPS
$0.48
Dividend yield
1.08%
Payout ratio
40.3%
Recent dividends

Financial health

How did National Research financials performed over time
NRC's total assets is 139% greater than its total liabilities
National Research's total liabilities has decreased by 17% YoY and by 6% QoQ
The quick ratio has declined by 12% year-on-year and by 2.9% since the previous quarter
National Research's debt is 74% lower than its equity
NRC's debt to equity is down by 28% YoY and by 7% QoQ
National Research's debt has decreased by 18% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.